Ed Hrubiec
About Ed Hrubiec
Ed Hrubiec is a Regional Access Manager and Regional Business Director at Amylyx Pharmaceuticals, specializing in rare diseases. He has extensive experience in the pharmaceutical industry, having held various roles at companies such as Intercept Pharmaceuticals, Gilead Sciences, and Vertex Pharmaceuticals.
Current Role at Amylyx Pharmaceuticals
Ed Hrubiec serves as the Regional Access Manager for the Northeast and the Regional Business Director for the West at Amylyx Pharmaceuticals. He has held these positions since 2022, focusing on rare diseases within the United States. His role involves overseeing access strategies and business development initiatives to enhance the availability of treatments for patients.
Previous Experience at Intercept Pharmaceuticals
Hrubiec worked at Intercept Pharmaceuticals in various capacities from 2018 to 2022. Initially, he served as the Regional Access Manager for the Northeast from 2018 to 2019. He then transitioned to the Area Access Director for the East from 2019 to 2022. His responsibilities included managing access strategies and facilitating patient access to rare disease therapies.
Professional Background at Gilead Sciences and Vertex Pharmaceuticals
Ed Hrubiec spent five years at Gilead Sciences as a Senior Therapeutic Specialist focusing on rare diseases from 2005 to 2010. He later joined Vertex Pharmaceuticals, where he held multiple roles, including Key Account Manager and National Director from 2010 to 2013. During his tenure at Vertex, he achieved notable success, including a national ranking of #1 among Key Account Managers in 2013.
Educational Background
Hrubiec earned a Bachelor of Science degree in Applied Professional Sciences with a minor in Business Marketing from the University of South Carolina. He attended the university from 1993 to 1998, completing his studies over a five-year period. His education has provided a foundation for his career in the pharmaceutical industry.
Recognition and Awards
Throughout his career, Ed Hrubiec has received several awards for his performance in sales and account management. Notably, he received the Pinnacle Award in 2012 for being the top-ranked Key Account Manager at Vertex Pharmaceuticals. He also earned the Vertex VOCAP Recognition Award in the same year, highlighting his contributions to the company's success.